Spring 2018 Seminar Series

FEB 09

Richard Schlegel, MD, PhD

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “Conditional cell reprogramming: modeling cancer and cell immortalization”

Professor, Georgetown University

FEB 23

Alexander J.R. Bishop, DPhil

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “Ataxia telangiectasia: a metabolic disease”

Associate Professor, UT Health, Greehey Children's Cancer Research Institute

MAR 09

Cigall Kadoch, PhD

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Disease”

Assistant Professor, Dana-Farber Cancer Institute

MAR 23

Janet Shipley, PhD

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “ATR as a Therapeutic Target in Synovial Sarcoma: Understanding the Possibilitiess”

Professor, The Institute of Cancer Research, London

APR 20

Jolanta Grembecka, PhD

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “New epigenetic therapies for acute leukemia”

>Associate Professor,University of Michigan

MAY 04

Masahiro Morita, PhD

11:00pm - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “mRNA translational control of cancer metabolism through the mTORC1/4E-BP pathway”

Assistant Professor, Department of Molecular Medicine, UT Health

MAY 18

Alberto S. Pappo, MD

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “What pediatric rare cancers can teach us”

Member, Director, Solid Tumor Division, St. Jude

MAY 18

Yves Pommier, MD, PhD

11:00am - 12:00pmAuditorium, 2.160 - Greehey CCRI

Lecture Title: “Precision Therapeutics with DNA Targeted Agentss”

Chief, NIH